![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Provention Bio Inc | NASDAQ:PRVB | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.98 | 25.04 | 24.90 | 0 | 01:00:00 |
Provention Bio, Inc.
|
(Name of Issuer)
|
Common Stock, $0.0001 par value
|
(Title of Class of Securities)
|
74374N102
|
(CUSIP Number)
|
December 31, 2019
|
(Date of Event which Requires Filing of this Statement)
|
☐
|
Rule 13d-1(b)
|
☐ |
Rule 13d-1(c)
|
☒ |
Rule 13d-1(d)
|
CUSIP No.
|
74374N102
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
MacroGenics, Inc.
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)☐
|
|||||
(b)☐
|
|
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
0%
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
CO
|
|
|
|||
|
|
(a) |
Name of Issuer: Provention Bio, Inc.
|
(b) |
Address of Issuer’s Principal Executive Offices: PO Box
666, Oldwick, New Jersey 08858
|
(a)
|
Name of Person Filing: MacroGenics, Inc.
|
(b)
|
Address of Principal Business Office or, if None, Residence: 9704 Medical Center Dr., Rockville, MD 20850
|
(c)
|
Citizenship: Delaware
|
(d)
|
Title and Class of Securities: Common
Stock, $0.0001 par value
|
(e)
|
CUSIP No.: 74374N102
|
Item 3. |
Statements filed pursuant to rules 13D-1(B) or 13D-2(B) or (C): Not applicable
|
Item 4. |
Ownership:
|
Item 5. |
Ownership of Five Percent or Less of a Class.
|
Item 6. |
Ownership of more than Five Percent on Behalf of Another Person. Not applicable
|
Item 7. |
Identification and classification of the subsidiary which acquired the security being reported
on by the parent holding company or control person. Not applicable
|
Item 8. |
Identification and classification of members of the group. Not applicable
|
Item 9. |
Notice of Dissolution of Group. Not applicable
|
Item 10. |
Certification. Not applicable
|
Date: February 20, 2020
|
MACROGENICS, INC.
|
|
By:
|
/s/ Jeffrey Peters
|
|
Jeffrey Peters
|
||
Vice President and General Counsel
|
1 Year Provention Bio Chart |
1 Month Provention Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions